|
|
Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes
Pierre Bigot
,
Jean-François Hétet
,
Jean-Christophe Bernhard
,
Tarek Fardoun
,
François Audenet
et al.
Journal articles
hal-01064296v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting
Jean-Alexandre Long
,
Jean-Christophe Bernhard
,
Pierre Bigot
,
Cécilia Lanchon
,
Philippe Paparel
et al.
Journal articles
hal-01792768v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE
Idir Ouzaid
,
Karim Bensalah
Journal articles
hal-01260239v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Exploring Biological Predictive Factors of Progression After Surgery in High-Risk Renal Cell Carcinoma: Results From the French Cohort of the Randomized S-TRAC Trial Patients
Idir Ouzaid
,
Solene Florence Kammerer-Jacquet
,
Zineddine Khene
,
Alain Ravaud
,
Jean-Jacques Patard
et al.
Journal articles
hal-03273658v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma
Zine-Eddine Khene
,
Pierre Bigot
,
Nicolas Doumerc
,
Idir Ouzaid
,
R. Boissier
et al.
Journal articles
hal-03775987v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|